<DOC>
	<DOCNO>NCT01855490</DOCNO>
	<brief_summary>The study design open label pilot trial analyze acute response glucose , GLP-1 , GIP , insulin secretory , glucagon mixed meal tolerance test ( MMTT ) intravenous glucose tolerance test ( IVGTT ) without pretreatment Exenatide ( Byetta ) 5 mcg sc . The investigator also test effect Exenatide gastric empty MMTT .</brief_summary>
	<brief_title>Study Acute Metabolic Effect Exenatide Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>T1D least 3 yrs duration . Male female age 1856 year meet American Diabetes Association standard T1DM criterion . HgbA1c &lt; 9 % Insulin requirement &lt; 0.8 U/kg/d Absence severe hypoglycemia past 6 month Absence ketoacidosis past 6 month Menstruating woman must negative pregnancy test willing avoid pregnancy study period . Signed informed consent.. Inability unwillingness give informed consent . Prior Exenatide Liraglutide treatment use medication could potentially affect diabetes immunologic status Known hypersensitivity Exenatide product component Participation investigational treatment trial within last 6 week enrollment . Any medical condition opinion investigator would interfere safe completion trial : epilepsy , atopic disease , active Grave 's disease , cystic fibrosis , sickle cell anemia , neuropathy , peripheral vascular disease , cerebrovascular disease , liver disease , HIV , concurrent autoimmune disease except treat stable thyroid disease Known severe renal impairment , endstage renal disease renal transplantation . Any history gastroparesis severe gastrointestinal disease , pancreatitis , thyroid nodule malignancy exclusion history localize basal cell carcinoma . Uncompensated heart failure , fluid overload , myocardial infarction liver disease within last 6 week enrollment . Active clinically serious infection . Positive pregnancy test menstruate woman lactate female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>56 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>